BRIDGEBIO PHARMA ($BBIO) posted quarterly earnings results on Thursday, February 20th. The company reported earnings of -$1.31 per share, missing estimates of -$1.15 by $0.16. The company also reported revenue of $5,880,000, beating estimates of $3,549,008 by $2,330,992.
You can see Quiver Quantitative's $BBIO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BRIDGEBIO PHARMA Insider Trading Activity
BRIDGEBIO PHARMA insiders have traded $BBIO stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:
- GENETIC DISORDER L.P. KKR sold 5,800,000 shares for an estimated $149,350,000
- GLOBAL INVESTORS LP VIKING sold 3,065,616 shares for an estimated $106,989,998
- NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 7 sales selling 658,932 shares for an estimated $23,542,500.
- BRIAN C STEPHENSON (Secretary, Treasurer & CFO) has made 0 purchases and 3 sales selling 76,304 shares for an estimated $2,710,871.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BRIDGEBIO PHARMA Hedge Fund Activity
We have seen 143 institutional investors add shares of BRIDGEBIO PHARMA stock to their portfolio, and 138 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT LLC added 2,448,000 shares (+140.1%) to their portfolio in Q4 2024, for an estimated $67,173,120
- CITADEL ADVISORS LLC removed 1,686,753 shares (-57.3%) from their portfolio in Q4 2024, for an estimated $46,284,502
- WOODLINE PARTNERS LP added 1,261,772 shares (+132.9%) to their portfolio in Q4 2024, for an estimated $34,623,023
- PERCEPTIVE ADVISORS LLC removed 1,215,346 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $30,942,709
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,089,492 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $27,738,466
- PICTET ASSET MANAGEMENT HOLDING SA removed 995,585 shares (-35.5%) from their portfolio in Q4 2024, for an estimated $27,318,852
- ALYESKA INVESTMENT GROUP, L.P. added 940,415 shares (+inf%) to their portfolio in Q4 2024, for an estimated $25,804,987
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
